Polycystic Ovary Syndrome (PCOS) is most common endocrine disorder during reproductive years. It is estimated that PCOS affects vary widely from 2 to 26 in every 100 women. The present study was intended to assess the clinical pharmacist role to reduce the risk factors and impact of counselling on lifestyle modification. Study design was Prospective observational study, study site at Department of Gynaecology and Obstetrics, Government General Hospital, Guntur and Study period was 6 months. Study results shows that, a total of 190 subjects were recruited into the study population based on inclusion and exclusion criteria the mean age of subjects was 24.33, and mean BMI was 37.27, most of the subjects were urban background. The mean age of menarche of the subjects was 12.43, the mean length of menstrual cycle was 32.01 and no of days bleeding during menstruation mean was 5.01. Regarding risk factors 100(52.62%) subjects complaining about stress, 68 subjects have the positive family history of PCOS, 76 subjects were obese. regarding sign and symptoms 163 complaining of irregular bleeding, 91 subjects with hirsutism and only 5 with Acanthosis, 109 complaining of weight gain after diagnosed with PCOS. After counselling about exercise and dietary modifications most of them changes their habits, impact of counseling on exercise and dietary modifications were calculated by chi-square test which gives the significant value p<0.0001**** for exercise and p<0.0001*** for dietary habits. Finally our study concluded that most of the risk factors were modifiable so, proper counselling by clinical pharmacist about risk factors and lifestyle modifications show the positive impact on disease outcome.
Impact Factor
2022: 6.012
This work is licensed under a